Your browser is no longer supported. Please, upgrade your browser.
MDT Medtronic plc monthly Stock Chart
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E33.19 EPS (ttm)2.57 Insider Own0.10% Shs Outstand1.38B Perf Week-2.76%
Market Cap118.02B Forward P/E16.48 EPS next Y5.18 Insider Trans-16.58% Shs Float1.38B Perf Month-1.67%
Income3.65B PEG4.16 EPS next Q1.12 Inst Own85.60% Short Float0.77% Perf Quarter-1.09%
Sales28.73B P/S4.11 EPS this Y2.90% Inst Trans-0.06% Short Ratio2.53 Perf Half Y13.87%
Book/sh36.51 P/B2.34 EPS next Y11.25% ROA3.60% Target Price94.89 Perf Year28.86%
Cash/sh9.27 P/C9.21 EPS next 5Y7.98% ROE7.10% 52W Range65.58 - 89.27 Perf YTD12.14%
Dividend1.72 P/FCF45.39 EPS past 5Y-2.60% ROI5.40% 52W High-3.21% Beta0.87
Dividend %2.01% Quick Ratio2.50 Sales past 5Y13.20% Gross Margin68.90% 52W Low31.75% ATR1.20
Employees88000 Current Ratio3.00 Sales Q/Q-1.50% Oper. Margin18.50% RSI (14)49.65 Volatility1.38% 1.26%
OptionableYes Debt/Eq0.63 EPS Q/Q15.70% Profit Margin12.70% Rel Volume0.88 Prev Close85.40
ShortableYes LT Debt/Eq0.59 EarningsAug 25 BMO Payout60.40% Avg Volume4.21M Price86.40
Recom2.00 SMA200.09% SMA50-0.56% SMA2007.26% Volume3,640,969 Change1.17%
Aug-26-16Reiterated Needham Buy $93 → $95
Aug-23-16Initiated Citigroup Buy $102
Jun-09-16Initiated Guggenheim Neutral
Jun-07-16Reiterated Needham Buy $90 → $93
Jun-01-16Reiterated Wedbush Neutral $79 → $82
Apr-25-16Initiated Sun Trust Rbsn Humphrey Buy $93
Apr-05-16Reiterated Needham Buy $88 → $90
Mar-17-16Initiated Nomura Buy
Mar-02-16Reiterated Needham Buy $91 → $88
Jun-03-15Reiterated Needham Buy $90 → $91
May-20-15Reiterated Needham Buy $87 → $90
Feb-18-15Reiterated Oppenheimer Outperform $82 → $84
Feb-13-15Reiterated Needham Buy $84 → $87
Jan-06-15Reiterated Needham Buy $81 → $84
Nov-25-14Reiterated RBC Capital Mkts Outperform $73 → $81
Nov-19-14Reiterated Oppenheimer Outperform $73 → $78
Nov-19-14Reiterated Needham Buy $74 → $81
Sep-30-14Initiated Needham Buy $74
Jun-18-14Upgrade Barclays Equal Weight → Overweight $67 → $73
Jun-18-14Reiterated Oppenheimer Outperform $66 → $73
Sep-30-16 02:56PM  Medtronics HeartWare System Recalled (MDT) at Investopedia
02:47PM  Analyzing Medtronics Recent Stock Performance
11:08AM  Medtronic Heart Pump Recall Deemed Life-Threatening by FDA at Bloomberg
10:30AM  Medtronic Gets FDA Approval for MiniMed 670G System
10:05AM  ZBHs Launch of Latest Vanguard System Strengthens Knee Portfolio
09:02AM  FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls GlobeNewswire
Sep-29-16 10:06AM  Medtronic Announces First Use of Sugar.IQ with Watson App
10:05AM  What Is Boston Scientifics Latest Valuation?
01:34AM  FDA approves 'artificial pancreas' to manage diabetes
12:09AM  [$$] FDA Approves Medtronics New Automated Insulin Pump at The Wall Street Journal
Sep-28-16 09:00PM  FDA approves 'artificial pancreas' to manage diabetes
08:30PM  [$$] FDA Approves Medtronic's New Automated Insulin Pump at The Wall Street Journal
06:10PM  Business Highlights
03:10PM  Medtronic 'artificial pancreas' tech gets FDA approval at bizjournals.com
02:39PM  The FDA just approved the first 'artificial pancreas'
01:59PM  Artificial Pancreas Approved by FDA Marks a Global First at Bloomberg
01:41PM  Medtronic artificial pancreas is the first to receive FDA approval at MarketWatch
01:40PM  U.S. FDA approves Medtronic's 'artificial pancreas' for diabetes Reuters
01:21PM  Medtronic Receives FDA Approval for World's First Hybrid Closed Loop System for People with Type 1 Diabetes GlobeNewswire
11:04AM  Why Johnson & Johnson's New Wearable for Diabetics Should Be a Home Run at Motley Fool
10:33AM  Medtronic Plc Value Analysis (NYSE:MDT) : September 28, 2016
09:03AM  Medtronic Receives FDA Clearance of TrailBlazer Angled Peripheral Support Catheter GlobeNewswire
Sep-27-16 11:45AM  New Research Reports for GE, McDonald's & GSK
10:47AM  Medtronic's StealthStation Software Gets FDA Clearance
09:03AM  Medtronic Announces First Live Experience of Sugar.IQ with Watson for People Living with Diabetes GlobeNewswire
09:03AM  The 3 Best-Run Companies in the Healthcare Sector at Motley Fool
08:34AM  Medtronic Plc breached its 50 day moving average in a Bearish Manner : MDT-US : September 27, 2016
08:18AM  Op-Ed: Mylan CEO's testimony was a huge blow to the entire pharma industry at CNBC
Sep-26-16 11:05AM  A Look at Johnson & Johnsons Recent Stock Performance
10:05AM  Inside Johnson & Johnsons Latest US Medical Device Launch
08:04AM  Medtronic's StealthStation® Cranial Software Receives FDA Clearance as an Aid for Deep Brain Stimulation Lead Placement GlobeNewswire
Sep-23-16 10:24AM  ETFs with exposure to Medtronic Plc : September 23, 2016
08:43AM  Medtronic (MDT): Valiant Captivia Data Positive at Three Years
Sep-22-16 09:01AM  Bull of the Day: Edwards Lifesciences (EW)
06:30AM  21st Century Cures Act: Pork Or Promise? at Forbes
Sep-20-16 12:31PM  Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years GlobeNewswire
Sep-19-16 08:15PM  Medtronic Plc (MDT) Chairman & CEO Omar Ishrak Sold $5.3 million of Shares
12:46PM  New Data Presented in VIVA Late Breaking Clinical Trials Demonstrate Durability, Safety and Efficacy for the Medtronic In.Pact Admiral DCB GlobeNewswire
10:04AM  Discussing St. Jude Medicals Latest Valuation
09:31AM  Analysis Shows Positive Association Between Cardiac Resynchronization Therapy and Patients' Increased Adherence to Heart Failure Medication Regimens GlobeNewswire
07:00AM  AxoGen, Inc. Appoints Amy Wendell to Board of Directors GlobeNewswire
Sep-18-16 11:13AM  Hate Checking Your Portfolio? Try These 2 Stocks at Motley Fool
Sep-16-16 05:04PM  Analyzing St. Jude Medicals Latest Dividend Payment
Sep-15-16 04:04PM  What Are Analysts Recommendations for Stryker?
03:04PM  Analyzing Strykers Latest Dividend Payment
09:06AM  Medtronic's Reveal Heart Monitor Launch in Japan Bodes Well
08:31AM  The Journal of the American Medical Association Publishes Medtronic's Hybrid Closed Loop System Pivotal Trial Results GlobeNewswire
08:02AM  Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services GlobeNewswire
07:37AM  Today's Top 5 Stock Picks: Oshkosh, Unilever, More at Barrons.com
Sep-14-16 09:57AM  Medtronic IN.PACT Admiral: First FDA-Approved DCB for ISR
09:02AM  Medtronic Announces Approval and Launch of Reveal LINQ(TM) Insertable Cardiac Monitor in Japan GlobeNewswire
Sep-13-16 06:15PM  Barrow, Hanley, Mewhinney & Strauss Reduces Stakes in 2nd Quarter
05:05PM  Perrenial Target and Acquirer NuVasive Names New President and COO
11:01AM  Medtronic Receives FDA Approval of First Drug-Coated Balloon for Treatment of In-Stent Restenosis (ISR) GlobeNewswire
Sep-12-16 04:04PM  A Look into Oracles Cloud Strategy to Chase Growth
09:02AM  New ESC Guidelines Support Recent Medtronic Innovations for Patients with Atrial Fibrillation GlobeNewswire
08:05AM  Medtronics Latest Analysts Recommendations Are Mostly Buys
Sep-10-16 01:04PM  MEDTRONIC PLC Financials
Sep-09-16 06:04PM  New Long-Term Data Reaffirm the Benefits of Medtronics Micra TPS
04:28PM  FDA Approves Medtronics Enlite Sensor for iPro2 CGM System
Sep-08-16 12:56PM  Medtronic Recognized as a Sustainability Leader GlobeNewswire
Sep-07-16 09:31AM  Medtronic's Enlite Sensor Gets FDA Nod for Diabetic Care
07:00AM  Opsens Appoints Pat Mackin to its Board of Directors CNW Group
06:48AM  MEDTRONIC PLC Files SEC form 10-Q, Quarterly Report
Sep-06-16 09:02AM  Medtronic CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare Conference GlobeNewswire
07:34AM  Medtronic Opens New Office in Vietnam, Strengthens Hold in Asia
Sep-05-16 08:10AM  Medtronic Plc breached its 50 day moving average in a Bullish Manner : MDT-US : September 5, 2016
Sep-04-16 11:00PM  Medtronic Establishes New Office in Vietnam PR Newswire
02:05PM  How Google Plans to Reinvent Healthcare at Motley Fool
Sep-01-16 10:22AM  Medtronic Gets FDA Approval Of Enlite Sensor For iPro®2 Professional Continuous Glucose Monitoring System
10:04AM  What Analysts Recommend for Medtronic after 1Q17 Earnings
10:01AM  Medtronic EVP & RTG President Geoff Martha to Speak at Wells Fargo Global Healthcare Conference GlobeNewswire
09:02AM  Medtronic Announces Approval of Enlite® Sensor for iPro®2 Professional Continuous Glucose Monitoring System in the U.S. GlobeNewswire
08:04AM  Medtronics Latest Valuation: Heres What You Need to Know
Aug-31-16 05:45PM  VGHCX, VWNFX: Top Mutual Fund Holders of Medtronic (MDT) at Investopedia
05:04PM  Edwards Lifesciences Capitalizes on Valve Replacement Market
04:04PM  Analyzing C.R. Bards Strong Product Pipeline
03:04PM  What Caused Edwards Lifesciences to Guide Higher?
12:34PM  Analysts Recommendations for C.R. Bard in 2016
11:04AM  A Look at Medtronics Updated Guidance for 2017
10:04AM  How Much Has Medtronic Returned to Shareholders in 1Q17?
09:00AM  Medtronic Posts Positive Long-term Data for Micra Pacemaker
08:04AM  Medtronics HeartWare Acquisition: The Must-Know Details
Aug-30-16 02:04PM  How Johnson & Johnsons Partnerships Enhance Customer Value
01:17PM  Why Intuitive Surgicals Revenues Are Expected to Be Weaker
01:16PM  Analysts Recommendations for Intuitive Surgical in 2016
11:04AM  Medtronics Operating Margins Missed Wall Street EstimatesAgain
10:05AM  Medtronics Diabetes Segment Sales: Must-Read Drivers in 1Q17
09:19AM  Post Earnings Coverage as Medtronic Earnings Surge 13 Percent on Lower Tax Bill
08:05AM  Analyzing Medtronics Sales Growth by Segment in 1Q17
Aug-29-16 06:04PM  Why Medtronics Stock Price Fell on 1Q17 Revenues
04:07PM  Medtronic Registers In-Line Earnings, Missed Revenue Estimates
10:02AM  Medtronic on Track with Covidien Synergy, Buys HeartWare
09:30AM  The Zacks Analyst Blog Highlights: Barclays, Medtronic, Procter & Gamble, Dollar Tree and AT&T
09:02AM  Medtronic Technologies Improve Delivery of Cardiac Resynchronization Therapy GlobeNewswire
Aug-28-16 10:32AM  New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker GlobeNewswire
Aug-26-16 04:16PM  Nike, Dollar General, Splunk Downgraded; Medtronic Price Target Hiked
10:36AM  ETFs with exposure to Medtronic Plc : August 26, 2016
10:23AM  Top Research Reports for August 26, 2016
09:47AM  Bulls targeting Medtronic after earnings
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company's Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company's Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kuntz RichardSrVP & Chief Scien, Clin, RegSep 27Sale86.7017,1411,486,056107,085Sep 28 04:25 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegSep 26Option Exercise35.9230,6241,100,014149,425Sep 28 04:25 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegSep 26Sale86.6725,1992,183,997124,226Sep 28 04:25 PM
Powell Kendall JDirectorSep 15Option Exercise44.4410,061447,08334,282Sep 19 05:06 PM
ISHRAK OMARChairman & CEOSep 15Sale84.9361,9255,259,414565,916Sep 19 04:45 PM
Powell Kendall JDirectorSep 15Sale85.457,907675,61426,375Sep 19 05:06 PM
Hanson Bryan CEVP, President, MITGAug 29Option Exercise29.5215,000442,800168,192Aug 31 03:24 PM
Hanson Bryan CEVP, President, MITGAug 29Sale87.0015,0001,305,000153,192Aug 31 03:24 PM
OLEARY DENISE MDirectorAug 16Option Exercise46.911,49370,03752,423Aug 17 03:18 PM
Hanson Bryan CEVP, President, MITGJul 26Option Exercise29.5215,000442,800108,717Jul 27 03:19 PM
Hanson Bryan CEVP, President, MITGJul 26Sale87.0015,0001,305,00093,717Jul 27 03:19 PM
Martha GeoffreyEVP & GroupPres Restora TherapJul 15Sale88.263,766332,40226,273Jul 19 01:57 PM
JACKSON SHIRLEY ADirectorJul 13Option Exercise51.312,600133,40936,093Jul 14 04:28 PM
Ellis Gary LeeEVP & Global Ops and ITJul 13Option Exercise48.7041,0682,000,012216,434Jul 14 04:40 PM
JACKSON SHIRLEY ADirectorJul 13Sale88.642,104186,49833,989Jul 14 04:28 PM
Ellis Gary LeeEVP & Global Ops and ITJul 13Sale88.6435,4953,146,206180,939Jul 14 04:40 PM
Surface Carol ASVP, Chief HR OfficerJul 06Sale87.089,787852,27359,784Jul 08 09:22 AM
Hanson Bryan CEVP, President, MITGJul 05Option Exercise27.2915,272416,773108,989Jul 06 04:32 PM
Hanson Bryan CEVP, President, MITGJul 05Sale87.1115,2721,330,34493,717Jul 06 04:32 PM
ANDERSON RICHARD HDirectorJun 24Option Exercise42.388,577363,47664,244Jun 28 02:02 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegJun 03Option Exercise40.7558,9002,400,049163,519Jun 07 12:56 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegJun 03Sale82.6049,9054,122,153113,614Jun 07 12:56 PM
TEN HOEDT ROBEVP & President EMEACJun 01Option Exercise36.0010,416375,02638,595Jun 03 01:27 PM
TEN HOEDT ROBEVP & President EMEACJun 01Sale80.5312,100974,40030,939Jun 03 01:27 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegApr 01Sale75.224,000300,879104,358Apr 05 04:16 PM
JACKSON SHIRLEY ADirectorMar 18Option Exercise46.911,49370,03731,305Mar 22 03:31 PM
JACKSON SHIRLEY ADirectorMar 18Sale75.601,23893,59329,812Mar 22 03:31 PM
ISHRAK OMARChairman & CEOMar 17Sale76.1523,7991,812,374600,738Mar 21 04:48 PM
ISHRAK OMARChairman & CEOMar 15Option Exercise34.88323,01311,266,693854,272Mar 17 04:48 PM
Hanson Bryan CEVP, President, MITGMar 04Sale75.005,000375,00096,806Mar 08 03:11 PM
Hanson Bryan CEVP, President, MITGFeb 05Sale76.145,000380,700101,806Feb 08 04:04 PM
Hanson Bryan CEVP & Pres Min Invas TherapiesJan 08Sale75.005,000375,000106,514Jan 11 03:14 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegDec 04Option Exercise48.7015,401750,029121,801Dec 08 04:07 PM
Kuntz RichardSrVP & Chief Scien, Clin, RegDec 04Sale78.0613,7151,070,644108,086Dec 08 04:07 PM